S 1954
119th Congress
Senate
Health
Drug safety, medical device, and laboratory regulation
Government information and archives
Licensing and registrations
Prescription drugs
Biosimilar Red Tape Elimination Act
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 17, 2026
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Jun 4, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 4, 2025
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
What's happening now
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Related & companion bills
1
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). S. 1954: Biosimilar Red Tape Elimination Act. 119th Congress. Open America. https://openamerica.io/bill/119-S-1954/
"S. 1954: Biosimilar Red Tape Elimination Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-1954/.
S. 1954, 119th Cong. (2026), https://openamerica.io/bill/119-S-1954/.
[S. 1954: Biosimilar Red Tape Elimination Act](https://openamerica.io/bill/119-S-1954/)